CLASS II Device recall · Reported 2 Dec 2015 · FDA Enforcement Report

Novocastra Lyophilized Mouse Monoclonal Antibody CD10 (CD10) recalled

Leica Microsystems is recalling Novocastra Lyophilized Mouse Monoclonal Antibody CD10 (CD10), distributed nationwide in the US. The recall was initiated on 3 Sep 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCD10-270-CE-S (0.1 ml) 6033086 (U.S. Distribution) expire 06/2016, 6032390 expires 04/2016, 6033622 expires 07/2016. CD10-270-CE (1ml) 6032742 (U.S. Distribution) expires 11/2017.
Quantity recalledU.S: 1 unit of CD10-270-CE-S & 66 units of CD10-270-CE. Foreign: 83 units of CD10-270-CE-S & 219 units of CD10-270-CE

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0341-2016
FDA event ID
72288
Recalling firm
Leica Microsystems, Buffalo Grove, IL
Classification
Class II
Status
Terminated
Recall initiated
3 Sep 2015
FDA classified
25 Nov 2015
Reported
2 Dec 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

3 Sep 2015Recall initiated by company
25 Nov 2015Classified by FDA+83 days
2 Dec 2015Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

These Lot numbers are not stable up to the expiry date on the product labeling.

Product as listed by the FDA

Novocastra Lyophilized Mouse Monoclonal Antibody CD10 (CD10). Immunohistochemistry. in vitro diagnostic. 0.1ml NCL-CD10-270 and 1mL NCL-CD10-270 are intended for the qualitative identification by light microscopy of CD10 molecules in paraffin sections.

Where it was distributed

Worldwide Distribution - US Nationwide, Australia, Austria, Brazil, Canada, China, Czech Republic, Finland, France, Germany, Hungary, Indonesia, Ireland, Israel, Italy, Japan, Netherlands, Norway, Romania, Singapore, Slovenia, South Korea, Spain, Sweden, Switzerland and UK.

Nationwide

Questions about this recall

Why was it recalled?

These Lot numbers are not stable up to the expiry date on the product labeling.

Which lots are affected?

CD10-270-CE-S (0.1 ml) 6033086 (U.S. Distribution) expire 06/2016, 6032390 expires 04/2016, 6033622 expires 07/2016. CD10-270-CE (1ml) 6032742 (U.S. Distribution) expires 11/2017.

Where was it sold?

Worldwide Distribution - US Nationwide, Australia, Austria, Brazil, Canada, China, Czech Republic, Finland, France, Germany, Hungary, Indonesia, Ireland, Israel, Italy, Japan, Netherlands, Norway, Romania, Singapore, Slovenia, South Korea, Spain, Sweden, Switzerland and UK.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Leica Microsystems

All 40

Other Test Kits & Diagnostics recalls

All 2,661